现代医药卫生2016，Vol.32Issue(9)：1281-1283,3.DOI:10.3969/j.issn.1009-5519.2016.09.001
高强度聚焦超声消融治疗子宫腺肌病合并子宫肌瘤的安全性及短期疗效评价
Evaluation on safety and short term efficacy of high intensity focused ultrasound ablation for treating adenomyosis co-existing with uterine leiomyomas
摘要
Abstract
Objective To evaluate the safety and short-term efficacy of high intensity focused ultrasound (HIFU) single ablation for treating adenomyosis coexisting with uterine leiomyomas. Methods The clinical data in the patients with adeno-myosis coexisting with leiomyomas underwent HIFU ablation in our hospital from April 2011 to June 2015 were collected. The pa-tients were performed the once HIFU ablation therapy. The occurrence rate of intraoperative and postoperative adverse reactions was evaluated. The lesion ablation rate was evaluated by postoperative MRI. The improvement situation of dysmenorrhea and men-orrhea at postoperative 1,3,6 months was followed up. Results All patients accomplished HIFU ablation without intraoperative and postoperative severe complications occurrence. The average ablation rates of adenomyosis and uterine fibroids lesions were 64.69%and 77.66%respectively. The dysmenorrhea score at postoperative 1 ,3,6 months in 41 patients with dysmenorrhea was significantly decreased compared with before operation,the difference was statistically significant(P<0.01);the dysmenorrheal com-plete relief rates were 85.37%,80.49%and 85.37%respectively,the dysmenorrheal partially relief rates were 7.32%,14.63%and 7.32%,respectively. The relief rates of 26 patients with menorrhagia at 1,3,6 months were 76.92%,73.08%and 69.23%respec-tively. Conclusion HIFU single ablation therapy has little adverse reactions and possesses better short term effect in treating adenomyosis coexisting with leiomyomas.关键词
超声,高强聚焦,经肠/导管消融术/平滑肌瘤/子宫肿瘤/子宫腺肌病Key words
Ultrasound,high-Intensity focused,transrecta/Catheter ablation/Leiomyoma/Uterine neoplasms/Uterine adenomyoma引用本文复制引用
王李纲,邹建中,邓勇斌,肖筱,汪清玲,陈骊,杨武林..高强度聚焦超声消融治疗子宫腺肌病合并子宫肌瘤的安全性及短期疗效评价[J].现代医药卫生,2016,32(9):1281-1283,3.基金项目
“十二五”国家科技支撑计划项目（2011BAI14B01）；973项目（2011CB707900）。 （）
